BCL2 protein expression in follicular lymphomas with t(14;18) chromosomal translocations
Open Access
- 27 January 2009
- journal article
- research article
- Published by Wiley in British Journal of Haematology
- Vol. 144 (5) , 716-725
Abstract
Summary: The t(14;18)(q32;q21) chromosomal translocation induces BCL2 protein overexpression in most follicular lymphomas. However the expression of BCL2 is not always homogeneous and may demonstrate a variable degree of heterogeneity. This study analysed BCL2 protein expression pattern in 33 cases of t(14;18)‐positive follicular lymphomas using antibodies against two different epitopes (i.e. the widely used antibody BCL2/124 and an alternative antibody E17). 16/33 (49%) cases demonstrated strong BCL2 expression. In 10/33 (30%) cases, BCL2 expression was heterogeneous and in some of these, its loss appeared to be correlated with cell proliferation, as indicated by Ki67 expression. Double immunofluorescence labelling confirmed an inverse BCL2/Ki67 relationship, where in 24/28 (86%) cases cellular expression of BCL2 and Ki67 was mutually exclusive. In addition, seven BCL2 ‘pseudo‐negative’ cases were identified in which immunostaining was negative with antibody BCL2/124, but positive with antibody E17. Genomic DNA sequencing of these ‘pseudo‐negative’ cases demonstrated eleven mutations in four cases and nine of these were missense mutations. It can be concluded that in follicular lymphomas, despite carrying the t(14;18) translocations, BCL2 protein expression may be heterogeneous and loss of BCL2 could be related to cell proliferation. Secondly, mutations in translocated BCL2 genes appear to be common and may cause BCL2 pseudo‐negative immunostaining.Keywords
This publication has 34 references indexed in Scilit:
- Detection of Genetic Alterations by ImmunoFISH Analysis of Whole Cells Extracted from Routine Biopsy MaterialThe Journal of Molecular Diagnostics, 2007
- Expression pattern of FCRL (FREB, FcRX) in normal and neoplastic human B cellsBritish Journal of Haematology, 2004
- Intronic BCL-6 mutations are preferentially targeted to the translocated allele in t(3;14)(q27;q32) non-Hodgkin B-cell lymphomaBlood, 2003
- Incidence and Clinical Significance of Bcl-2 / IgH Rearrangements in Follicular LymphomaLeukemia & Lymphoma, 2003
- BCL-xL and BCL2 delay Myc-induced cell cycle entry through elevation of p27 and inhibition of G1 cyclin-dependent kinasesOncogene, 2002
- Absence of Somatic Hypermutation in the Open Reading Frame of the Bcl-2 Gene Participating in the t(14;18) Chromosomal Translocation in Follicular LymphomaLeukemia & Lymphoma, 2002
- Heterogeneity in cell proliferation and expression of p53 and bcl‐2 during the indolent phase of germinal centre cell lymphoma: an explanation for clinical variabilityBritish Journal of Haematology, 1995
- The protein bcl-2 alpha does not require membrane attachment, but two conserved domains to suppress apoptosis.Journal of Cell Biology, 1994
- Multiple Recurrent Genomic Defects in Follicular LymphomaNew England Journal of Medicine, 1987
- Cloning and structural analysis of cDNAs for bcl-2 and a hybrid bcl-2/immunoglobulin transcript resulting from the t(14;18) translocationCell, 1986